Home  >  Products  >  CD27 (CD27 molecule) Blocking Peptide (the C terminal of CD27)(100ug)
CD27 (CD27 molecule) Blocking Peptide (the C terminal of CD27)(100ug)

CD27 (CD27 molecule) Blocking Peptide (the C terminal of CD27)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-CD27 Antibody(ARP59093_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP59093
Size: 100ug
Weight: 27kDa
Gene: 939
Format: Lyophilized powder
Target: The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is required for generation and long-term maintenance of T cell immunity. It binds to ligand CD70, and plays a key role in regulating B-cell activation and immunoglobulin synthesis. This receptor transduces signals that lead to the activation of NF-kappaB and MAPK8/JNK. Adaptor proteins TRAF2 and TRAF5 have been shown to mediate the signaling process of this receptor. CD27-binding protein (SIVA), a proapoptotic protein, can bind to this receptor and is thought to play an important role in the apoptosis induced by this receptor.
Alternative names: MGC20393; S152; T14; TNFRSF7; Tp55
See Full Product Listings >